Scientists found that dormant viral genes can be reactivated in kidney cancer, prompting an immune…
Browsing: Dana-Farber Cancer Institute
Dana-Farber Cancer Institute, located in Boston, Massachusetts, is a world-renowned leader in cancer treatment and research. Established in 1947, the institute is a principal teaching affiliate of Harvard Medical School and serves as a cancer treatment center within the broader Harvard-affiliated hospitals. Dana-Farber is recognized for its commitment to providing cancer patients with the best treatment available while advancing the understanding and treatment of cancer through innovative research. The institute’s research program is one of the largest cancer research enterprises in the world, with a vast array of clinical trials and cutting-edge studies in oncology. Dana-Farber also emphasizes patient care, offering a holistic approach that focuses on both physical and emotional well-being. Its contributions to the development of cancer treatments, such as chemotherapy, targeted therapies, and immunotherapies, have significantly impacted cancer survival rates and quality of life for patients globally.
A study from the Dana-Farber Cancer Institute indicates that unintentional weight loss is linked to…
Recent research shows that proteins’ intrinsically disordered regions (IDRs) are critical for chromatin regulation and…
Investigational drug works differently than antibody drugs which are losing effectiveness against the COVID-19 virus.…
A New Mechanism Links Mutations in Areas Devoid of Genes to Cancer For many years,…
Consuming higher amounts of Vitamin D – mainly from dietary sources – may help protect…
Marijuana smoking found to raise levels of potentially harmful chemicals but to a lesser degree…
New research suggests a way to increase the staying power of CAR T cells, a…
A newly published study from the Dana-Farber Cancer Institute reveals that vitamin D can protect…
A Phase I clinical trial of an implantable vaccine to treat melanoma has begun. A…
In a newly published study, researchers observed a strong and selective immune response in some…
Two newly discovered TERT promoter mutations were found to be even more common than BRAF…
A newly published study found that a diet heavy in complex sugars and carbohydrate-rich foods…
A newly published study shows that aspirin can be effective in prolonging survival among patients…
A recent study showed that using the combined treatment of kinase inhibitors dabrafenib and trametinib,…
A team of researchers isolated and determined the unique genetic profile of beige fat for…
New research from the Harvard Medical School and the Dana-Farber Cancer Institute examines why a…